Inventor · disambiguated record
Ping Cai
Also filed as: CAI PING
13 granted patents·11 pending applications·71 citations·filing 2002–2025
90Inventor score
Top patents by PatentIndex Score
24 records- 0196US7445916B2Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodiesWYETH CORP·Filed 2005·Granted Nov 4, 2008·22 cites·12 claims
- 0292US7268144B2Regiospecific synthesis of rapamycin 42-ester derivativesWYETH CORP·Filed 2005·Granted Sep 11, 2007·23 cites·14 claims
- 0389US9950058B2RSV F protein mutantsPFIZER·Filed 2016·Granted Apr 24, 2018·9 cites·44 claims
- 0484US12364749B2RSV F protein mutantsPFIZER·Filed 2023·Granted Jul 22, 2025·0 cites·18 claims
- 0584US2025312435A1RSV F Protein MutantsPFIZER·Filed 2025·Application pending·0 cites
- 0683US7332601B2CCI-779 derivatives and methods of making sameWYETH CORP·Filed 2005·Granted Feb 19, 2008·9 cites·10 claims
- 0782US10821171B2RSV F protein mutantsPFIZER·Filed 2019·Granted Nov 3, 2020·1 cites·20 claims
- 0877US7625726B2Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodiesWYETH CORP·Filed 2008·Granted Dec 1, 2009·2 cites·25 claims
- 0972US7666901B2Analogs of 17-hydroxywortmannin as PI3K inhibitorsWYETH CORP·Filed 2005·Granted Feb 23, 2010·2 cites·15 claims
- 1071US2021023200A1RSV F Protein MutantsPFIZER·Filed 2020·Application pending·0 cites
- 1167US11155664B2Polymeric nanoparticles useful in theranosticsGOVERNING COUNCIL UNIV TORONTO·Filed 2018·Granted Oct 26, 2021·0 cites·18 claims
- 1267US7498327B2Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2005·Granted Mar 3, 2009·1 cites·20 claims
- 1364US10238732B2RSV F protein mutantsPFIZER·Filed 2018·Granted Mar 26, 2019·0 cites·41 claims
- 1463US6914045B2Glycopeptide antibioticsWYETH CORP·Filed 2002·Granted Jul 5, 2005·2 cites·128 claims
- 1559US10233277B2Polymeric nanoparticles useful in theranosticsGOVERNING COUNCIL UNIV TORONTO·Filed 2013·Granted Mar 19, 2019·0 cites·16 claims
- 1655US2024025950A1Method of purification of recombinantly-produced rsv proteins in trimeric formPFIZER·Filed 2021·Application pending·0 cites
- 1755US2023330136A1Blood-brain barrier-penetrating nanotheranostics for acute and chronic neurodegenerative diseases and the likeGOVERNING COUNCIL UNIV TORONTO·Filed 2021·Application pending·0 cites
- 1852US2010279364A1CCI-779 derivatives and methods of making sameWYETH CORP·Filed 2007·Application pending·0 cites
- 1951US2008255057A1Prodrug substituted benzoxazoles as estrogenic agentsWYETH CORP·Filed 2008·Application pending·0 cites
- 2048US2007099931A1Pharmaceutical dosage forms and compositionsWYETH CORP·Filed 2006·Application pending·0 cites
- 2145US2004138302A1Antifungal antibioticsWYETH CORP·Filed 2003·Application pending·0 cites
- 2244US2006046968A1Prodrug substituted benzoxazoles as estrogenic agentsWYETH CORP·Filed 2005·Application pending·0 cites
- 2343US2010028952A1Fermentation and purification of actinomadura chromoprotein and related speciesWYETH CORP·Filed 2007·Application pending·0 cites
- 2433US2005215561A1Pharmaceutical dosage forms and compositionsGHOSH KRISHNENDU·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ping Cai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →